Mitochondrial fragmentation in liver cancer: Emerging player and promising therapeutic opportunities.

[1]  Qi Zhang,et al.  FUNDC2 promotes liver tumorigenesis by inhibiting MFN1-mediated mitochondrial fusion , 2022, Nature Communications.

[2]  R. Bataller,et al.  Loss of hepatic DRP1 exacerbates alcoholic hepatitis by inducing megamitochondria and mitochondrial maladaptation , 2022, Hepatology.

[3]  B. Chen,et al.  Mitochondrial micropeptide STMP1 enhances mitochondrial fission to promote tumor metastasis. , 2022, Cancer research.

[4]  Ruibin Xi,et al.  Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma , 2022, Nature Communications.

[5]  Xuekang Yang,et al.  Mitochondrial fission factor promotes cisplatin resistancein hepatocellular carcinoma , 2022, Acta biochimica et biophysica Sinica.

[6]  Meixiao Zhan,et al.  PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma , 2022, Gut.

[7]  Q. Gao,et al.  PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma. , 2022, Journal of hepatology.

[8]  Charles T. Hindmarch,et al.  Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance , 2022, Nature Cell Biology.

[9]  J. Xing,et al.  Mitochondrial fragmentation is crucial for c-Myc-driven hepatoblastoma-like liver tumor. , 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  A. Dhawan,et al.  Emergencies in Pediatric hepatology. , 2022, Journal of hepatology.

[11]  J. Xing,et al.  Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1 , 2022, Cancer communications.

[12]  R. Deng,et al.  Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis , 2021, Signal Transduction and Targeted Therapy.

[13]  V. Mazzaferro,et al.  Immunotherapies for hepatocellular carcinoma , 2021, Nature Reviews Clinical Oncology.

[14]  F. Dai,et al.  Reactive Oxygen Species Mediate 6c-Induced Mitochondrial and Lysosomal Dysfunction, Autophagic Cell Death, and DNA Damage in Hepatocellular Carcinoma , 2021, International journal of molecular sciences.

[15]  S. Campello,et al.  PD‐1‐induced T cell exhaustion is controlled by a Drp1‐dependent mechanism , 2021, Molecular oncology.

[16]  Jun‐liang Fu,et al.  Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B. , 2021, Journal of hepatology.

[17]  Ruibin Xi,et al.  Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level. , 2021, Cancer discovery.

[18]  Long Zhao,et al.  DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer. , 2021, Journal of hepatology.

[19]  R. Geiger,et al.  Metabolic modulation of tumours with engineered bacteria for immunotherapy , 2021, Nature.

[20]  Libing Song,et al.  Epigenetic Induction of Mitochondrial Fission Is Required for Maintenance of Liver Cancer–Initiating Cells , 2021, Cancer Research.

[21]  R. Schwabe,et al.  Focal Adhesion Kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation. , 2021, Journal of hepatology.

[22]  L. Boulter,et al.  Build to understand biliary oncogenesis via organoids and FGFR2 fusion proteins. , 2021, Journal of hepatology.

[23]  T. Horvath,et al.  Mitochondrial Fission Governed by Drp1 Regulates Exogenous Fatty Acid Usage and Storage in Hela Cells , 2021, Metabolites.

[24]  C. Leonetti,et al.  FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma. , 2021, Journal of hepatology.

[25]  M. V. Vander Heiden,et al.  The Metabolic Landscape of RAS-Driven Cancers from biology to therapy , 2021, Nature Cancer.

[26]  W. Han,et al.  Reprogramming of mitochondrial proline metabolism promotes liver tumorigenesis , 2021, Amino Acids.

[27]  C. Peano,et al.  Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma. , 2021, Journal of hepatology.

[28]  Huanming Yang,et al.  Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma , 2020, Cell.

[29]  Ruibin Xi,et al.  Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression , 2020, Cell Discovery.

[30]  D. Figarella-Branger,et al.  SCENITH: A Flow Cytometry-Based Method to Functionally Profile Energy Metabolism with Single-Cell Resolution. , 2020, Cell metabolism.

[31]  Zhixiong Li,et al.  Tumor-derived adenosine promotes macrophage proliferation in human hepatocellular carcinoma. , 2020, Journal of hepatology.

[32]  Ying S. Ting,et al.  A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer , 2020, Cell.

[33]  Hongcheng Luo,et al.  LncRNA LL22NC03-N14H11.1 promoted hepatocellular carcinoma progression through activating MAPK pathway to induce mitochondrial fission , 2020, Cell Death & Disease.

[34]  Chuanyue Wu,et al.  PINCH-1 regulates mitochondrial dynamics to promote proline synthesis and tumor growth , 2020, Nature Communications.

[35]  U. Laufs,et al.  Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. , 2020, Journal of hepatology.

[36]  Y. Chen,et al.  Engineering CAR-T Cells for Next-Generation Cancer Therapy. , 2020, Cancer cell.

[37]  Wei Min,et al.  Metabolic activity phenotyping of single cells with multiplexed vibrational probes. , 2020, Analytical chemistry.

[38]  Jin Jin,et al.  The essential functions of mitochondrial dynamics in immune cells , 2020, Cellular & Molecular Immunology.

[39]  Hongyang Wang,et al.  Trajectory and Functional Analysis of PD‐1high CD4+CD8+ T Cells in Hepatocellular Carcinoma by Single‐Cell Cytometry and Transcriptome Sequencing , 2020, Advanced science.

[40]  Oncogenic driver genes and tumor microenvironment determine the type of liver cancer , 2020, Cell Death & Disease.

[41]  Tian-Le Xu,et al.  DUSP6 SUMOylation protects cells from oxidative damage via direct regulation of Drp1 dephosphorylation , 2020, Science Advances.

[42]  L. Scorrano,et al.  The cell biology of mitochondrial membrane dynamics , 2020, Nature Reviews Molecular Cell Biology.

[43]  R. Bataller,et al.  Perturbations in mitochondrial dynamics are closely involved in the progression of Alcoholic Liver Disease. , 2020, Alcoholism, clinical and experimental research.

[44]  X. Zong,et al.  Metabolic Symbiosis in Chemoresistance: Refocusing the Role of Aerobic Glycolysis , 2020, Frontiers in Oncology.

[45]  M. Yi,et al.  Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers , 2020, Cancer Research.

[46]  Feng Li,et al.  DRP1 upregulation promotes pancreatic cancer growth and metastasis through increased aerobic glycolysis , 2020, Journal of gastroenterology and hepatology.

[47]  M. Ho,et al.  Reliability of a Single-region Sample to evaluate Immune Tumor Microenvironment in Hepatocellular Carcinoma. , 2020, Journal of hepatology.

[48]  J. Xing,et al.  SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer. , 2020, Cancer letters.

[49]  C. Ye,et al.  Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma. , 2019, Journal of hepatology.

[50]  L. Qin,et al.  MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming , 2019, British Journal of Cancer.

[51]  Q. Gao,et al.  PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma , 2019, Journal of Immunotherapy for Cancer.

[52]  Takla Griss,et al.  Metabolic Profiling Using Stable Isotope Tracing Reveals Distinct Patterns of Glucose Utilization by Physiologically Activated CD8+ T Cells. , 2019, Immunity.

[53]  Yongguan Jiang,et al.  Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance , 2019, Nature Immunology.

[54]  David F. Kashatus,et al.  Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth , 2019, Cell reports.

[55]  Abhishek Mitra,et al.  Epigenetic Control of Mitochondrial Fission Enables Self-Renewal of Stem-like Tumor Cells in Human Prostate Cancer. , 2019, Cell metabolism.

[56]  Mary E. Choi,et al.  Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis , 2019, Nature Communications.

[57]  L. Hui,et al.  Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes , 2019, Nature Cell Biology.

[58]  J. Copland,et al.  Aberrant lipid metabolism as a therapeutic target in liver cancer , 2019, Expert opinion on therapeutic targets.

[59]  M. Orozco,et al.  Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease , 2019, Cell.

[60]  Yibing Chen,et al.  Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression , 2019, Oncogene.

[61]  G. Xiao,et al.  Kindlin-2 links mechano-environment to proline synthesis and tumor growth , 2019, Nature Communications.

[62]  B. Garcia,et al.  Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis. , 2019, Cancer discovery.

[63]  S. Campello,et al.  Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming , 2018, Cell reports.

[64]  X. Fang,et al.  Fatty acid oxidation: An emerging facet of metabolic transformation in cancer. , 2018, Cancer letters.

[65]  Hui Li,et al.  MTP18 overexpression contributes to tumor growth and metastasis and associates with poor survival in hepatocellular carcinoma , 2018, Cell Death & Disease.

[66]  Xiaohu Zheng,et al.  Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression. , 2018, Cell metabolism.

[67]  J. Prudent,et al.  Mitochondrial dynamics: overview of molecular mechanisms , 2018, Essays in biochemistry.

[68]  John M. Ashton,et al.  AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells. , 2018, Cell stem cell.

[69]  E. Maywood,et al.  Generation of circadian rhythms in the suprachiasmatic nucleus , 2018, Nature Reviews Neuroscience.

[70]  C. Ward,et al.  Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment , 2018, BMC Cancer.

[71]  Nektarios Tavernarakis,et al.  The Role of Mitophagy in Innate Immunity , 2018, Front. Immunol..

[72]  Deliang Guo,et al.  Lipid metabolism reprogramming and its potential targets in cancer , 2018, Cancer communications.

[73]  Adam Frost,et al.  Structural Basis of Mitochondrial Receptor Binding and Constriction by DRP1 , 2018, Nature.

[74]  Steven A. Brown,et al.  Circadian Control of DRP1 Activity Regulates Mitochondrial Dynamics and Bioenergetics. , 2018, Cell metabolism.

[75]  Erika L. Pearce,et al.  Mitochondrial Dynamics at the Interface of Immune Cell Metabolism and Function. , 2018, Trends in immunology.

[76]  Xin-Hua Feng,et al.  Mitochondrial dynamics controls anti-tumour innate immunity by regulating CHIP-IRF1 axis stability , 2017, Nature Communications.

[77]  C. Garlanda,et al.  IL-1R8 is a checkpoint in NK cells regulating anti-tumor and anti-viral activity , 2017, Nature.

[78]  Zhe Wang,et al.  Mitochondrial fission forms a positive feedback loop with cytosolic calcium signaling pathway to promote autophagy in hepatocellular carcinoma cells. , 2017, Cancer letters.

[79]  Frank McCormick,et al.  RAS Proteins and Their Regulators in Human Disease , 2017, Cell.

[80]  Boxi Kang,et al.  Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing , 2017, Cell.

[81]  Darjus F. Tschaharganeh,et al.  Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS. , 2017, Cancer cell.

[82]  L. Hui,et al.  Fatty acid synthesis is critical for stem cell pluripotency via promoting mitochondrial fission , 2017, The EMBO journal.

[83]  J. Li,et al.  Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress , 2017, Oncogene.

[84]  J. Xing,et al.  NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25A , 2017, Cell Death & Disease.

[85]  Yibin Kang,et al.  Lipid Metabolism Fuels Cancer's Spread. , 2017, Cell metabolism.

[86]  D. Chan,et al.  Mfn1 structures reveal nucleotide-triggered dimerization critical for mitochondrial fusion , 2017, Nature.

[87]  Jihye Kim,et al.  T-cell-restricted intracellular antigen 1 facilitates mitochondrial fragmentation by enhancing the expression of mitochondrial fission factor , 2016, Cell Death and Differentiation.

[88]  G. Voeltz,et al.  Multiple Dynamin family members collaborate to drive mitochondrial division , 2016, Nature.

[89]  Taeghwan Hyeon,et al.  pH-Sensitive Pt Nanocluster Assembly Overcomes Cisplatin Resistance and Heterogeneous Stemness of Hepatocellular Carcinoma , 2016, ACS central science.

[90]  W. Guo,et al.  NK cell development requires Tsc1-dependent negative regulation of IL-15-triggered mTORC1 activation , 2016, Nature Communications.

[91]  M. Neurath,et al.  PGAM5-mediated programmed necrosis of hepatocytes drives acute liver injury , 2016, Gut.

[92]  Brandon Da Silva,et al.  NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer , 2016, Cell.

[93]  O. Kretz,et al.  Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming , 2016, Cell.

[94]  Chih-Hung Lee,et al.  Role of mitochondria, ROS, and DNA damage in arsenic induced carcinogenesis. , 2016, Frontiers in bioscience.

[95]  J. Li,et al.  MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism , 2016, PloS one.

[96]  J. Xing,et al.  Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways , 2016, Autophagy.

[97]  E. Nice,et al.  HBV-induced ROS accumulation promotes hepatocarcinogenesis through Snail-mediated epigenetic silencing of SOCS3 , 2016, Cell Death and Differentiation.

[98]  C. Thompson,et al.  The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.

[99]  Á. Raya,et al.  Early ERK1/2 activation promotes DRP1-dependent mitochondrial fission necessary for cell reprogramming , 2015, Nature Communications.

[100]  William B. Mair,et al.  Hepatic Bmal1 Regulates Rhythmic Mitochondrial Dynamics and Promotes Metabolic Fitness. , 2015, Cell metabolism.

[101]  A. B. Reddy,et al.  Circadian redox oscillations and metabolism , 2015, Trends in Endocrinology & Metabolism.

[102]  Jianjun Wang,et al.  Enhancement of ovarian cancer chemotherapy by delivery of multidrug‐resistance gene small interfering RNA using tumor targeting Salmonella , 2015, The journal of obstetrics and gynaecology research.

[103]  K. Hoehn,et al.  Erk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth. , 2015, Molecular cell.

[104]  William A. Flavahan,et al.  Mitochondrial Control by DRP1 in Brain Tumor Initiating Cells , 2015, Nature Neuroscience.

[105]  H. Kondoh,et al.  Dysregulated glycolysis as an oncogenic event , 2015, Cellular and Molecular Life Sciences.

[106]  M. Abdellatif,et al.  Endogenous Drp1 Mediates Mitochondrial Autophagy and Protects the Heart Against Energy Stress , 2015, Circulation research.

[107]  Glenn E. Simmons,et al.  Diverse Roles of SIRT1 in Cancer Biology and Lipid Metabolism , 2015, International journal of molecular sciences.

[108]  P. Schumacker,et al.  Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? , 2014, Nature Reviews Cancer.

[109]  H. Ye,et al.  Synergistic function of Kras mutation and HBx in initiation and progression of hepatocellular carcinoma in mice , 2014, Oncogene.

[110]  Xu Wang,et al.  Silencing NPAS2 promotes cell growth and invasion in DLD-1 cells and correlated with poor prognosis of colorectal cancer. , 2014, Biochemical and biophysical research communications.

[111]  Maxim N. Artyomov,et al.  Cell-intrinsic lysosomal lipolysis is essential for macrophage alternative activation , 2014, Nature Immunology.

[112]  A. Siddiqui,et al.  Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence , 2014, Proceedings of the National Academy of Sciences.

[113]  Ying Zhang,et al.  Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. , 2014, Cell stem cell.

[114]  A. Siddiqui,et al.  Hepatitis B Virus Disrupts Mitochondrial Dynamics: Induces Fission and Mitophagy to Attenuate Apoptosis , 2013, PLoS pathogens.

[115]  Yong-Mahn Han,et al.  Unveiling the critical role of REX1 in the regulation of human stem cell pluripotency , 2013, Stem cells.

[116]  D. Klionsky,et al.  Mitochondrial fission facilitates mitophagy in Saccharomyces cerevisiae , 2013, Autophagy.

[117]  C. Blackstone,et al.  SUMO wrestling with Drp1 at mitochondria , 2013, The EMBO journal.

[118]  John M. Asara,et al.  Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway , 2013, Nature.

[119]  D. Chan,et al.  Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission , 2013, Molecular biology of the cell.

[120]  H. Basaga,et al.  Inactivation of Bcl‐2 through IκB kinase (IKK)‐dependent phosphorylation mediates apoptosis upon exposure to 4‐hydroxynonenal (HNE) , 2012, Journal of cellular physiology.

[121]  G. V. D. Windt,et al.  Metabolic switching and fuel choice during T‐cell differentiation and memory development , 2012, Immunological reviews.

[122]  J. Menéndez,et al.  Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: New insight into the role of mitophagy in cell stemness , 2012, Aging.

[123]  E. Wherry,et al.  Progressive Loss of Memory T Cell Potential and Commitment to Exhaustion during Chronic Viral Infection , 2012, Journal of Virology.

[124]  Gerald C. Chu,et al.  Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.

[125]  C. Huang,et al.  Calcineurin serves in the circadian output pathway to regulate the daily rhythm of L‐type voltage‐gated calcium channels in the retina , 2012, Journal of cellular biochemistry.

[126]  Alberto Mantovani,et al.  Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.

[127]  D. Green,et al.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.

[128]  Toshio Matsumoto,et al.  Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells , 2011, PloS one.

[129]  Linda Partridge,et al.  Unraveling the biological roles of reactive oxygen species. , 2011, Cell metabolism.

[130]  J. Rathmell,et al.  Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.

[131]  L. Scorrano,et al.  During autophagy mitochondria elongate, are spared from degradation and sustain cell viability , 2011, Nature Cell Biology.

[132]  A. Chawla,et al.  Alternative macrophage activation and metabolism. , 2011, Annual review of pathology.

[133]  Yanrui Li,et al.  miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1 , 2011, Nature Medicine.

[134]  Guido Kroemer,et al.  Autophagy and the integrated stress response. , 2010, Molecular cell.

[135]  R. Schwarzenbacher,et al.  Membrane Remodeling Induced by the Dynamin-Related Protein Drp1 Stimulates Bax Oligomerization , 2010, Cell.

[136]  T. Prolla,et al.  Mitochondrial Fusion Is Required for mtDNA Stability in Skeletal Muscle and Tolerance of mtDNA Mutations , 2010, Cell.

[137]  J. Pouysségur,et al.  Hypoxia-induced autophagy: cell death or cell survival? , 2010, Current opinion in cell biology.

[138]  G. Felsenfeld,et al.  H4R3 methylation facilitates beta-globin transcription by regulating histone acetyltransferase binding and H3 acetylation. , 2010, Blood.

[139]  Herbert Yu,et al.  The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer , 2010, Breast Cancer Research and Treatment.

[140]  P. Vogt,et al.  Akt‐mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt , 2009, International journal of cancer.

[141]  Paolo Sassone-Corsi,et al.  Metabolism and cancer: the circadian clock connection , 2009, Nature Reviews Cancer.

[142]  Kurt Straif,et al.  A review of human carcinogens--Part F: chemical agents and related occupations. , 2009, The Lancet. Oncology.

[143]  A. Godzik,et al.  S-Nitrosylation of Drp1 Mediates β-Amyloid-Related Mitochondrial Fission and Neuronal Injury , 2009, Science.

[144]  Joseph C. Sun,et al.  Adaptive Immune Features of Natural Killer Cells , 2009, Nature.

[145]  A. Nebreda,et al.  AKT and oxidative stress team up to kill cancer cells. , 2008, Cancer cell.

[146]  D. Fischman,et al.  Vitamin A depletion causes oxidative stress, mitochondrial dysfunction, and PARP‐1‐dependent energy deprivation , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[147]  Peng Huang,et al.  Redox regulation of cell survival. , 2008, Antioxidants & redox signaling.

[148]  Y. Yoon,et al.  Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. , 2008, Cardiovascular research.

[149]  S. Pattingre,et al.  JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. , 2008, Molecular cell.

[150]  Kurt Straif,et al.  Carcinogenicity of shift-work, painting, and fire-fighting. , 2007, The Lancet. Oncology.

[151]  R. Strong,et al.  Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands , 2007, Nature.

[152]  R. Rizzuto,et al.  Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. , 2007, Molecular cell.

[153]  Chi V Dang,et al.  Cancer's molecular sweet tooth and the Warburg effect. , 2006, Cancer research.

[154]  P. Schumacker,et al.  Reactive oxygen species in cancer cells: live by the sword, die by the sword. , 2006, Cancer cell.

[155]  A. Holmgren,et al.  Motexafin Gadolinium, a Tumor-selective Drug Targeting Thioredoxin Reductase and Ribonucleotide Reductase* , 2006, Journal of Biological Chemistry.

[156]  S. Hell,et al.  Spatial and temporal dynamics of budding yeast mitochondria lacking the division component Fis1p , 2003, Journal of Cell Science.

[157]  R. Stevens,et al.  Night shift work, light at night, and risk of breast cancer. , 2001, Journal of the National Cancer Institute.

[158]  C. Allis,et al.  Methylation of Histone H4 at Arginine 3 Facilitating Transcriptional Activation by Nuclear Hormone Receptor , 2001, Science.

[159]  J. Welsh,et al.  Role of Mitochondria and Caspases in Vitamin D-mediated Apoptosis of MCF-7 Breast Cancer Cells* , 2001, The Journal of Biological Chemistry.

[160]  H R Herschman,et al.  PRMT1 Is the Predominant Type I Protein Arginine Methyltransferase in Mammalian Cells* , 2000, The Journal of Biological Chemistry.

[161]  D. Aswad,et al.  Regulation of transcription by a protein methyltransferase. , 1999, Science.

[162]  Y. Tu,et al.  The LIM-Only Protein PINCH Directly Interacts with Integrin-Linked Kinase and Is Recruited to Integrin-Rich Sites in Spreading Cells , 1999, Molecular and Cellular Biology.

[163]  J. O'fallon,et al.  Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. , 1979, The New England journal of medicine.